To clarify the genetic correlation between parkin and PINK1, we screened for PINK1 mutations in 175 parkinsonism patients with parkin mutations. We detected two sibling pairs and one sporadic patient carrying both parkin and PINK1 mutations. The age at onset of Parkinsonism of patients with the digenic mutations was lower than that of patients with the same parkin mutation alone. In addition, two of three patients carrying both parkin and PINK1 mutations had schizophrenia. These findings indicate that PINK1 mutation might modify parkin mutation-positive Parkinsonism, and PINK1 mutations might be associated with psychiatric disorders.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mds.22143 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lead Phytomolecules for Treating Parkinson's Disease.
Cent Nerv Syst Agents Med Chem
December 2024
Dr. A.P.J. Abdul Kalam Technical University, Lucknow-226031, India.
One percent of persons over 65 years of age suffer from Parkinson's disease, a neurological ailment marked by dopaminergic neurons in the nigrostriatal pathway gradually dying and being depleted in the striatum. Parkin and PINK1 gene mutations, which are essential for mitophagy and impair mitochondrial function, are the cause of it. Parkinson's disease is linked to a number of motor and impairment disorders, including bradykinesia, rigid muscles, tremor at rest, and imbalance.
View Article and Find Full Text PDFInhibition of the PI3K-AKT-MTORC1 axis reduces the burden of the m.3243A>G mtDNA mutation by promoting mitophagy and improving mitochondrial function.
Autophagy
December 2024
Department of Cell and Developmental Biology and Consortium for Mitochondrial Research, UCL, London, UK.
Mitochondrial DNA (mtDNA) encodes genes essential for oxidative phosphorylation. The m.3243A>G mutation causes severe disease, including myopathy, lactic acidosis and stroke-like episodes (MELAS) and is the most common pathogenic mtDNA mutation in humans.
View Article and Find Full Text PDFβ-asarone relieves Parkinson's disease through reducing intracellular Ca in PINK1 mutant Drosophila melanogaster.
Eur J Pharmacol
January 2025
School of Pharmacy, Anhui Medical University, Hefei, 230032, Anhui, China. Electronic address:
β-asarone, an effective volatile oil component of Acorus chinensis, has been found to hold beneficial effects on Parkinson's disease (PD), but its mechanism remains incompletely understood. Drosophila melanogaster with PTEN induced kinase 1 (PINK1) mutations, a prototype PD model, was used in this study. We found that calcium chelation profoundly alleviated a spectrum of PD symptoms.
View Article and Find Full Text PDFTargeting ATAD3A Phosphorylation Mediated by TBK1 Ameliorates Senescence-Associated Pathologies.
Adv Sci (Weinh)
November 2024
Guangdong Cardiovascular Institute, Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Targeting cellular senescence, one of the hallmarks of aging and aging-related pathologies emerges as an effective strategy for anti-aging and cancer chemotherapy. Here, a switch from TBK1-OPTN axis to TBK1-ATAD3A axis to promote cellular senescence is shown. Mechanically, TBK1 protein is abnormally activated and localized to the mitochondria during senescence, which directly phosphorylates ATAD3A at Ser321.
View Article and Find Full Text PDFInsulin Resistance Is a Modifying Factor for Parkinson's Disease.
Mov Disord
November 2024
Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Article Synopsis
- Parkinson's disease (PD) is a common neurodegenerative disorder linked to non-genetic risk factors, with central insulin resistance emerging as a potential contributor to its pathology.
- This study investigates the relationship between insulin resistance and the severity of symptoms in patients with the GBA1-N370S mutation-associated PD, using midbrain organoids for analysis.
- Results indicate that altered insulin signaling genes are involved in GBA-PD and that targeting FOXO1 may protect against neuron loss, with the anti-diabetic drug Pioglitazone showing promise as a treatment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!